Breast cancer and hormone receptors: a preliminary report.
An assay is available to determine the presence or absence of oestrogen receptors in breast cancer cells. The presence of oestrogen receptors predicts a 60% response rate to empirical hormonal therapy, and the absence a 10% response rate. Early evidence suggests that the additional presence of other hormone receptors in breast cancer cells will improve this response rate.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000032:analysis* / Q000188:drug therapy; D004958:Estradiol; D004965:Estrogen Antagonists / Q000627:therapeutic use; D006801:Humans; D011960:Receptors, Estrogen / Q000032:analysis*
D000970:Antineoplastic Agents; D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D004958:Estradiol